AMA Group (ASX: AMA)’s recovery story is now being tested by whether improving earnings can translate into durable cash flow across its collision repair network, rather than fading as a short-term rebound. The business has moved beyond a pure survival narrative, but operating risks in parts of the network and still-soft repair volumes mean the…
Radiopharm Theranostics (ASX:RAD) is increasingly defined by whether its lead imaging asset RAD101 can convert encouraging mid-stage data into a credible registrational pathway, against a backdrop where clinical and execution risk remains high. The company has assembled a broad oncology radiopharmaceutical pipeline, but its near-term valuation still centres on whether one program can move from…
3P Learning (ASX: 3PL)’s valuation now hinges on whether the business review can arrest B2B school churn and declining revenue before the longer-term value in Reading Eggs, Mathletics and its expanding US homeschool channel is eroded. The urgency is clear from the half-year result: revenue fell to $51.9m and underlying EBITDAA to $5.7m, prompting management…
IperionX (ASX: IPX) is now a trade-off between the cash-hungry ramp-up at its Virginia Titanium Manufacturing Campus and the longer-term value of a government-backed domestic titanium platform that already has funding, feedstock and a permitted upstream asset in Titan. With Virginia online at 200tpa and expanding toward 1,400tpa, the company has moved beyond technology claims…
Telix Pharmaceuticals, The Clock Is Now Running
For many investors following Telix Pharmaceuticals (ASX:TLX), the story has been the sharp fall in the share price after the FDA setback, with the stock dropping almost 70% from its high to its low. What is becoming clearer now is that the company is taking real steps toward…
Amazon AI trade comes back, is it time to buy some stock
Amazon is continuing to see strong growth through AWS, which is helping offset concerns around the scale of its capex buildout. In our view, that matters because over the long term Amazon still looks attractive, especially with AWS backlog expected to move toward…
It is that time of year again when Amazon releases its annual shareholder letter (along with the 1997 letter all over again) and the bottom line was that Amazon is making returns from AI - real returns, $15bn in a quarter to be exact! In our view, that number reframes both Amazon’s trajectory and the…
A handful of ASX Stocks Benefit From the NDIS, but could lose if a long-cried for crackdown actually happens. We're not saying they'll go out of business, but the gravy train might slow down.
What are the Best ASX Stocks to invest in?
Check our buy/sell tips
[sg_popup id="23914" event="click"][/sg_popup]
The explosion of the NDIS
What began as…
CrowdStrike (NDQ:CRWD) has evolved well beyond its origins as an endpoint security vendor. The 15-year old Texan company now functions as a de facto operating system for enterprise threat defence, a position that matters more as AI expands the attack surface faster than human teams can respond. The Falcon platform’s ARR-driven model, expanding module footprint,…
Thursday was a rough day if you owned ASX energy stocks given oil crashed 15%. Woodside (ASX:WDS) fell more than 10%. Santos (ASX:STO) dropped 6%. Beach Energy (ASX:BPT) slid 7%. The rest of the ASX actually rallied on the same day, making energy the one sector left bleeding.
And it was all because Trump announced a…
